SQY Therapeutics
Designing genetic disease treatments
- B2B
About SQY Therapeutics
A French biotechnology company specializing in designing and producing tricyclo-DNA antisense oligonucleotides for R&D programs targeting genetic diseases, specifically neuromuscular diseases
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Guyancourt, Île-de-France, France
- Founded
- 2015
- Revenue
- $5.8M – $46.1MTamtam estimate
- Website
- sqy-therapeutics.com
SQY Therapeutics at a glance
SQY Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Guyancourt, Île-de-France, France.
SQY Therapeutics was founded in 2015.
SQY Therapeutics has 11–50 employees.
SQY Therapeutics's revenue is $5.8M – $46.1M (Tamtam estimate).
Frequently asked questions about SQY Therapeutics
What is SQY Therapeutics's revenue?
Tamtam estimates SQY Therapeutics's annual revenue at $5.8M – $46.1M.
How many employees does SQY Therapeutics have?
SQY Therapeutics has 11–50 employees.
Where is SQY Therapeutics headquartered?
SQY Therapeutics is headquartered in Guyancourt, Île-de-France, France.
Selling to companies like SQY Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies